TriWest Adds Symetria Recovery to the Veterans Community Care Network to Provide Outpatient Addiction Services

El Paso, Texas, Jan. 22, 2021 (GLOBE NEWSWIRE) — Attributable to a legacy of treating veterans with specialty addiction recovery services, Symetria Recovery is pleased to announce its affiliation with TriWest Healthcare Alliance to care for veterans. TriWest was formed to serve the health care needs of the military and Veteran communities. TriWest was awarded the Community Care Network (CCN) Region 4 contract by the U.S. Department of Veterans Affairs (VA), enhancing access to health care for America’s Veterans in support of the VA’s critical mission. 

 

In turn, TriWest added Symetria Recovery as an outpatient provider of addiction recovery services via care strategies orchestrated with the veteran’s primary VA healthcare provider. “The Mission Act, approved by Congress in 2018, allows select providers such as Symetria to open our doors to veterans, enabling them to receive care often closer to where they live and work. Our employees were delighted to work alongside the VA to bring services directly to the communities where veterans and their families live,” states Symetria Recovery CEO Drew McCartney.

 

Symetria Recovery provides outpatient addiction recovery in a uniquely data-proven method combining Medically Assisted Treatment (MAT) with Intensive Outpatient (IOP) therapy – all under one roof.  Symetria Recovery assigns every Vet a team of care professionals who work together to treat the entire person – including physical, mental, emotional, and behavioral needs, that contribute to a comprehensive and enduring recovery.  VA referrals are expedited, every effort is made to see Vet patients on the same day as the referral.  Walk-ins are also welcome.

 

Veteran’s loved ones and VA healthcare locations are encouraged to call Symetria Recovery 24/7 at 866-721-2159 with questions.  

Symetria Recovery Texas Locations include: 

  • College Station, 1651 Rock Prairie Road, S 101, College Station, TX 77845
  • Jersey Village, 17347 Village Green, S 104, Houston, TX 77040
  • Spring, 635 Rayford Road, Suite E, Spring, TX 77386
  • Fort Worth, 7229 Hawkins View Drive, Fort Worth, TX 76132
  • Hurst, 1813 Harwood Court, Hurst, TX 76054 
  • Lewisville, 1850 Lakepointe Drive, #400, Lewisville, TX 75057

###

Symetria Recovery is the pioneer and leader in complete, personalized, evidence-based recovery care through outpatient opioid, heroin, and alcohol (all substance abuse) treatment committed to providing state-of-the-art, whole-person care, not just the addictive or dependency behavior. Its unique approach to dependency is known as The Symetria Method. This method combines medication-assisted treatment (MAT), psychiatry, and support from a single treatment team of behavioral health, medical and psychiatric professionals to reduce the risk of relapse and give patients sustainable results. Symetria Recovery’s highly successful outcomes have been validated by an independent, retrospective analysis of more than 1.5 billion commercial claims from 3+ million OUD patients for five years. The analysis demonstrates superior results on all metrics when compared with treatment as usual.  

Symetria Recovery currently operates six locations in Illinois (Des Plaines, Highland Park, Joliet, Lakeview/Chicago, Naperville, and Palos Heights) and six in Texas (College Station, Fort Worth, Hurst, Jersey Village, Lewisville and Spring). To help patients suffering from a substance use disorder find facilities that deliver quality treatment and care, Blue Cross and Blue Shield of Illinois (BCBSIL) recognizes all six of Symetria Recover’s Illinois locations with its Blue Distinction® Center for Substance Use Treatment and Recovery (BDC Substance Use Treatment and Recovery) designation – a new designation under the Blue Distinction Specialty Care program. 

To learn more, please visit www.symetriarecovery.com.



AnnMarie Fauske
Symetria Recovery
630-328-2574
[email protected]

UPCOMING DEADLINE REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Semiconductor Manufacturing International Corporation and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

PR Newswire

LOS ANGELES, Jan. 22, 2021 /PRNewswire/ — The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Semiconductor Manufacturing International Corporation (“SMIC” or “the Company”) (OTC: SMICY) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Investors who purchased the Company’s securities between April 23, 2020 and September 26, 2020, inclusive (the ”Class Period”), are encouraged to contact the firm before February 8, 2021.           

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm’s website at www.schallfirm.com, or by email at [email protected].

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading statements to the market. SMIC suffered from an increased chance of U.S. sanctions due to an “unacceptable risk” that equipment supplied to the Company would be used for military applications. Due to these restrictions, the Company’s suppliers would require “difficult-to-obtain” individual export licenses. Based on these facts, the Company’s public statements were false and materially misleading. When the market learned the truth about SMIC, investors suffered damages.

Join the case to recover your losses.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/upcoming-deadline-reminder-the-schall-law-firm-announces-the-filing-of-a-class-action-lawsuit-against-semiconductor-manufacturing-international-corporation-and-encourages-investors-with-losses-in-excess-of-100-000-to-contact-the-301213228.html

SOURCE The Schall Law Firm

INVESTOR ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Qiwi plc and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

PR Newswire

LOS ANGELES, Jan. 22, 2021 /PRNewswire/ — The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Qiwi plc (“Qiwi” or “the Company”) (NASDAQ: QIWI) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Investors who purchased the Company’s securities between March 28, 2019 and December 9, 2020, inclusive (the ”Class Period”), are encouraged to contact the firm before February 9, 2021.           

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm’s website at www.schallfirm.com, or by email at [email protected].

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading statements to the market. Qiwi failed to maintain effective internal controls over reporting and record-keeping. As a result, the Central Bank of Russia imposed restrictions on the Company’s ability to make payments to foreign merchants and to transfer money to pre-paid cards, among other penalties. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about Qiwi, investors suffered damages.

Join the case to recover your losses.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/investor-action-alert-the-schall-law-firm-announces-the-filing-of-a-class-action-lawsuit-against-qiwi-plc-and-encourages-investors-with-losses-in-excess-of-100-000-to-contact-the-firm-301213223.html

SOURCE The Schall Law Firm

First Industrial Realty Trust To Host Fourth Quarter And Full Year 2020 Results Conference Call On February 11th

PR Newswire

CHICAGO, Jan. 22, 2021 /PRNewswire/ — First Industrial Realty Trust, Inc. (NYSE: FR), a leading fully integrated owner, operator, and developer of industrial real estate, will host its fourth quarter and full year 2020 results conference call on Thursday, February 11, 2021 at 10:00 a.m. CST (11:00 a.m. EST). The conference call may be accessed by dialing (866) 542-2938 and entering the conference ID 4091295. The conference call will also be webcast live on the Investors page of the Company’s website at www.firstindustrial.com.

First Industrial’s fourth quarter and full year 2020 results will be released on Wednesday, February 10, 2021 after market close and will be available on the Company’s website.

A replay of the conference call will be available shortly after the call through Friday, February 26, 2021. For the replay, please dial (855) 859-2056, conference ID 4091295. The replay will also be available on the Company’s website.


About First Industrial Realty Trust, Inc.

First Industrial Realty Trust, Inc. (NYSE: FR) is a leading fully integrated owner, operator, and developer of industrial real estate with a track record of providing industry-leading customer service to multinational corporations and regional customers. Across major markets in the United States, our local market experts manage, lease, buy, (re)develop, and sell bulk and regional distribution centers, light industrial, and other industrial facility types. In total, we own and have under development approximately 64.1 million square feet of industrial space as of September 30, 2020.  For more information, please visit us at www.firstindustrial.com.


Forward-Looking Information

This press release and the presentation to which it refers may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934. We intend for such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995. Forward-looking statements are based on certain assumptions and describe our future plans, strategies and expectations, and are generally identifiable by use of the words “believe,” “expect,” “plan,” “intend,” “anticipate,” “estimate,” “project,” “seek,” “target,” “potential,” “focus,” “may,” “will,” “should” or similar words. Although we believe the expectations reflected in forward-looking statements are based upon reasonable assumptions, we can give no assurance that our expectations will be attained or that results will not materially differ. Factors which could have a materially adverse effect on our operations and future prospects include, but are not limited to: changes in national, international, regional and local economic conditions generally and real estate markets specifically; changes in legislation/regulation (including changes to laws governing the taxation of real estate investment trusts) local economic conditions generally and real estate markets specifically; changes in legislation/regulation (including changes to laws governing the taxation of real estate investment trusts) and actions of regulatory authorities; the uncertainty and economic impact of pandemics, epidemics or other public health emergencies or fear of such events, such as the recent outbreak of coronavirus disease 2019 (COVID-19); our ability to qualify and maintain our status as a real estate investment trust; the availability and attractiveness of financing (including both public and private capital) and changes in interest rates; the availability and attractiveness of terms of additional debt repurchases; our ability to retain our credit agency ratings; our ability to comply with applicable financial covenants; our competitive environment; changes in supply, demand and valuation of industrial properties and land in our current and potential market areas; our ability to identify, acquire, develop and/or manage properties on favorable terms; our ability to dispose of properties on favorable terms; our ability to manage the integration of properties we acquire; potential liability relating to environmental matters; defaults on or non-renewal of leases by our tenants; decreased rental rates or increased vacancy rates; higher-than-expected real estate construction costs and delays in development or lease-up schedules; potential natural disasters and other potentially catastrophic events such as acts of war and/or terrorism; litigation, including costs associated with prosecuting or defending claims and any adverse outcomes; risks associated with our investments in joint ventures, including our lack of sole decision-making authority; and other risks and uncertainties described under the heading “Risk Factors” and elsewhere in our annual report on Form 10-K for the year ended December 31, 2019, as well as those risks and uncertainties discussed from time to time in our other Exchange Act reports and in our other public filings with the SEC. We caution you not to place undue reliance on forward-looking statements, which reflect our outlook only and speak only as of the date of this press release or the dates indicated in the statements. We assume no obligation to update or supplement forward-looking statements. For further information on these and other factors that could impact us and the statements contained herein, reference should be made to our filings with the SEC.

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/first-industrial-realty-trust-to-host-fourth-quarter-and-full-year-2020-results-conference-call-on-february-11th-301213208.html

SOURCE First Industrial Realty Trust, Inc.

American Industrial Partners Announces Extension of SEACOR Holdings Inc. Tender Offer

American Industrial Partners Announces Extension of SEACOR Holdings Inc. Tender Offer

NEW YORK–(BUSINESS WIRE)–
American Industrial Partners has announced that Safari Merger Subsidiary, Inc. (“Purchaser”), an affiliate of American Industrial Partners, has extended until 9:00 p.m. Eastern Time on Thursday, February 4, 2021 the expiration time for its previously announced cash tender offer to purchase all of the outstanding shares of common stock (the “Shares”) of SEACOR Holdings Inc. (NYSE:CKH) (“SEACOR”) at a price of $41.50 per share. The tender offer, which was previously scheduled to expire at one minute after 11:59 p.m., Eastern Time, on January 21, 2021, was extended to allow additional time to meet the minimum tender condition that shares actually delivered (excluding shares tendered pursuant to guaranteed delivery procedures) represent at least 66 2/3% of all outstanding Shares.

American Stock Transfer & Trust Company, LLC, the depository for the tender offer, has indicated that, as of the prior expiration time, a total of approximately 5,804,953 Shares, representing approximately 27.84% of the outstanding Shares, had been validly tendered. The amount tendered includes approximately 69,601 Shares delivered pursuant to guaranteed delivery procedures that had been validly tendered pursuant to the Offer. Shareholders who have already tendered their Shares do not have to re-tender their Shares or take any other action as a result of the extension of the tender offer.

The tender offer is being made pursuant to the tender offer materials (including an Offer to Purchase, a related Letter of Transmittal and certain other offer documents) in the Tender Offer Statement on Schedule TO (together with any amendments or supplements thereto, the “Tender Offer Statement”) filed by Purchaser and its affiliates with the United States Securities and Exchange Commission on December 18, 2020, as amended.

About American Industrial Partners

American Industrial Partners is an operationally oriented private equity firm that makes control investments in industrial businesses serving domestic and global markets. The firm has deep roots in the industrial economy and has been active in private equity investing since 1989. To date, American Industrial Partners has completed over 100 transactions and currently has more than $7 billion of assets under management on behalf of leading pension, endowment and financial institutions. For more information on American Industrial Partners, visit www.americanindustrial.com.

Additional Information and Where to Find It

The tender offer described in this communication commenced on December 18, 2020. This communication is for informational purposes only and is neither an offer to purchase nor a solicitation of an offer to sell shares of SEACOR. On December 18, 2020, the bidders filed with the United States Securities and Exchange Commission (the “SEC”) a Tender Offer Statement on Schedule TO, and SEACOR filed with the SEC a Solicitation/Recommendation Statement on Schedule 14D-9. SEACOR’S STOCKHOLDERS AND OTHER INVESTORS ARE URGED TO READ THE TENDER OFFER MATERIALS (INCLUDING AN OFFER TO PURCHASE, A RELATED LETTER OF TRANSMITTAL AND CERTAIN OTHER TENDER OFFER DOCUMENTS) AND THE SOLICITATION/RECOMMENDATION STATEMENT BECAUSE THEY CONTAIN IMPORTANT INFORMATION WHICH SHOULD BE READ CAREFULLY BEFORE ANY DECISION IS MADE WITH RESPECT TO THE TENDER OFFER. The Tender Offer Statement and the Solicitation/Recommendation Statement are available for free at the SEC’s web site at www.sec.gov. Additional copies may be obtained for free by contacting SEACOR. Free copies of these materials and certain other offering documents will be made available by SEACOR upon request by mail to SEACOR Holdings Inc., 2200 Eller Drive, P.O. Box 13038, Fort Lauderdale, FL 33316, attention: Investor Relations, or by phone at 1-954-523-2200, or by directing requests for such materials to the information agent for the offer named in the Tender Offer Statement. Copies of the documents filed with the SEC by SEACOR will be available free of charge under the “Investors” section of SEACOR’s internet website at seacorholdings.com. In addition to the Offer to Purchase, the related Letter of Transmittal and certain other tender offer documents, as well as the Solicitation/Recommendation Statement, SEACOR files annual, quarterly and current reports, proxy statements and other information with the SEC. SEACOR’s filings with the SEC are also available for free to the public from commercial document-retrieval services and at the website maintained by the SEC at www.sec.gov.

Information Agent Contact

Michael Madalon

D.F. King & Co., Inc.

212-269-5732 / 917-294-9326

[email protected]

Media Contact

Stephen Pettibone / Mike DeGraff

Sard Verbinnen & Co.

[email protected]

KEYWORDS: New York United States North America

INDUSTRY KEYWORDS: Banking Other Professional Services Professional Services Finance

MEDIA:

PolarityTE, Inc. Announces Exercise of Warrants for Gross Proceeds of $7.67 Million

PolarityTE, Inc. Announces Exercise of Warrants for Gross Proceeds of $7.67 Million

SALT LAKE CITY–(BUSINESS WIRE)–
PolarityTE, Inc. (Nasdaq: PTE), a company focused on transforming the lives of patients by discovering, designing, and developing a range of regenerative tissue products and biomaterials, today announced the agreement by an accredited investor to exercise certain warrants to purchase up to an aggregate of 10,688,043 shares of common stock having an exercise price of $0.624 issued by the company in December 2020. The shares of common stock issuable upon exercise of the warrants are registered pursuant to a registration statement on Form S-3 (File No. 333-229584). In consideration for the immediate exercise of the warrants for cash, the company will sell to the exercising holder an additional warrant pursuant to the registration statement. The new warrant will be exercisable into an aggregate of up to 8,016,033 shares of common stock at an exercise price of $1.20 per share and a term of exercise equal to five years. The purchase price of the additional warrant will be $1,002,004, or $0.125 per warrant share.

The gross proceeds to the company from the exercise of the warrants and the sale of the additional warrants are expected to be $7,671,343, prior to deducting placement agent fees and estimated offering expenses.

H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering.

The Company currently intends to use the net proceeds from the offering for working capital and general corporate purposes.

The securities described above are being offered by PolarityTE pursuant to a “shelf” registration statement on Form S-3 (File No. 333-229584) previously filed with the U.S. Securities and Exchange Commission (“SEC”) on February 8, 2019 and declared effective by the SEC on February 22, 2019. Such securities may be offered only by means of a prospectus, including a prospectus supplement, forming a part of the effective registration statement. A final prospectus supplement and the accompanying prospectus relating to the offering will be filed with the SEC and will be available on the SEC’s website at www.sec.gov. Alternatively, when available, electronic copies of the final prospectus supplement and the accompanying prospectus may be obtained from H.C. Wainwright & Co., LLC, 430 Park Avenue, New York, NY 10022, by email at [email protected] or by phone at (646) 975-6996.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About PolarityTE®

PolarityTE is focused on transforming the lives of patients by discovering, designing, and developing a range of regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering and material sciences. Rather than manufacturing with synthetic and foreign materials within artificially engineered environments, PolarityTE manufactures products from the patient’s own tissue and uses the patient’s own body to support the regenerative process. From a small piece of healthy autologous tissue, the company creates an easily deployable, dynamic, and self-propagating product designed to regenerate the target tissues. PolarityTE’s innovative methods are intended to promote and accelerate growth of the patient’s tissues to undergo a form of effective regenerative healing.

Forward Looking Statements

Certain statements contained in this release are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. They are generally identified by words such as “believes,” “may,” “expects,” “anticipates,” “intend,” “plan,” “will,” “would,” “should” and similar expressions and include statements about the completion of the warrant exercise transaction, the satisfaction of customary closing conditions related to the closing of that transaction and the intended use of net proceeds from the offering. Readers should not place undue reliance on such forward-looking statements, which are based upon the Company’s beliefs and assumptions as of the date of this release. The Company’s actual results could differ materially due to the impact of the COVID-19 pandemic and FDA regulatory matters, which cannot be predicted, and the risk factors and other items described in more detail in the “Risk Factors” section of the Company’s Annual Reports and other filings with the SEC (copies of which may be obtained at www.sec.gov). Subsequent events and developments may cause these forward-looking statements to change. The Company specifically disclaims any obligation or intention to update or revise these forward-looking statements as a result of changed events or circumstances that occur after the date of this release, except as required by applicable law. Our actual results could differ materially due to risk factors and other items described in more detail in the “Risk Factors” section of the Company’s Annual Reports and other filings with the SEC (copies of which may be obtained at www.sec.gov).

POLARITYTE, the POLARITYTE logo, SKINTE, WHERE SELF REGENERATES SELF and WELCOME TO THE SHIFT are trademarks or registered trademarks of PolarityTE, Inc.

Investors:

Rich Haerle

VP, Investor Relations

PolarityTE, Inc.

[email protected]

(385) 315-0697

KEYWORDS: Utah United States North America

INDUSTRY KEYWORDS: Health Biotechnology

MEDIA:

Logo
Logo

Cascades to Release Fourth Quarter 2020 Financial Results on February 25, 2021

PR Newswire

KINGSEY FALLS, QC, Jan. 22, 2021 /PRNewswire/ – Cascades Inc. (TSX: CAS) will release its fourth quarter 2020 financial results before market open on Thursday, February 25, 2021, and will hold a conference call at 9:00 AM ET, to discuss the results. The conference call can be accessed by phone or via the company’s website:


Dial-in number:       


1-888-231-8191 / 1-647-427-7450 (international)


Replay:  


1-855-859-2056 / 1-416-849-0833 (international)


Access code # 5877077


(available until March 25, 2021)


Webcast (live and archived):  



www.cascades.com

, “Investor” section

Founded in 1964, Cascades offers sustainable, innovative and value-added solutions for packaging, hygiene and recovery needs. The company employs 11,000 women and men, who work in over 90 production units in North America and Europe. With its management philosophy, half a century of experience in recycling, and continuous efforts in research and development as driving forces, Cascades continues to deliver the innovative products that customers have come to rely on, while contributing to the well-being of people, communities and the planet. Cascades’ shares trade on the Toronto Stock Exchange under the ticker symbol CAS.

Website: www.cascades.com 
Green by Nature Blog: blog.cascades.com 
Facebook: facebook.com/Cascades
Twitter: twitter.com/CascadesDD | twitter.com/CascadesSD | twitter.com/CascadesInvest
YouTube: youtube.com/Cascades

Cision View original content:http://www.prnewswire.com/news-releases/cascades-to-release-fourth-quarter-2020-financial-results-on-february-25-2021-301213218.html

SOURCE Cascades Inc.

IIROC Trading Resumption – ORE

Canada NewsWire

VANCOUVER, BC, Jan. 22, 2021 /CNW/ – Trading resumes in:

Company: Orezone Gold Corporation

TSX-Venture Symbol: ORE

All Issues: Yes

Resumption (ET): 9:30 AM

IIROC can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. IIROC is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada.

SOURCE Investment Industry Regulatory Organization of Canada (IIROC) – Halts/Resumptions

Gridsum Holding Inc. to Hold Extraordinary General Meeting of Shareholders

PR Newswire

BEIJING, Jan. 22, 2021 /PRNewswire/ — Gridsum Holding Inc. (“Gridsum” or the “Company”) (NASDAQ:GSUM), a leading provider of cloud-based big-data analytics and artificial intelligence (“AI”) solutions in China, today announced it has called an extraordinary general meeting of shareholders (the “EGM”), to be held on February 22, 2021 at 10:00 a.m. (Beijing time), at Gridsum, South Wing, High Technology Building, No. 229 North 4th Ring Road, Haidian District, Beijing 100083, People’s Republic of China, to consider and vote upon, among other things, the proposal to authorize and approve the previously announced agreement and plan of merger, dated September 30, 2020 (the “Merger Agreement”), among the Company, Gridsum Corporation, an exempted company with limited liability incorporated under the laws of the Cayman Islands (“Parent”), and Gridsum Growth Inc., an exempted company with limited liability incorporated under the laws of the Cayman Islands and a wholly-owned subsidiary of Parent (“Merger Sub”), the plan of merger (the “Plan of Merger”) required to be filed with the Registrar of Companies of the Cayman Islands in connection with the Merger (as defined below), and the transactions contemplated by the Merger Agreement and the Plan of Merger, including the Merger.

Pursuant to the Merger Agreement and the Plan of Merger, at the effective time of the Merger, Merger Sub will merge with and into the Company, with the Company continuing as the surviving company and becoming a wholly-owned subsidiary of Parent (the “Merger”). If the Merger is completed, the Company will become a privately-held company, and, as a result of the Merger, the Company’s American depositary shares (“ADSs”), each representing one class B ordinary share of the Company, par value US$ 0.001 per share (the “Class B Ordinary Shares”), will no longer be listed on the NASDAQ Global Select Market and the Company’s American depositary shares program will terminate. In addition, the ADSs and the Class B Ordinary Shares represented by the ADSs will cease to be registered under Section 12 of the Securities Exchange Act of 1934 following the completion of the Merger.

The Company’s board of directors (the “Board”), acting upon the unanimous recommendation of a special committee of Board, composed solely of directors who are unaffiliated with any person participating as a buyer or rollover securityholder in the Merger or any member of the management of the Company, authorized and approved the execution, delivery and performance of the Merger Agreement, the Plan of Merger, and the consummation of the transactions contemplated thereby, including the Merger, and resolved to recommend that the Company’s Shareholders vote FOR, among other things, the proposal to authorize and approve the Merger Agreement, the Plan of Merger and the consummation of the transactions contemplated thereby, including the Merger.

Shareholders of record at the close of business in the Cayman Islands on February 8, 2021 are entitled to attend and vote at the EGM or any adjournment thereof. ADS holders as of the close of business in New York City on January 27, 2021 will be entitled to instruct Citibank, N.A., the ADS depositary, to vote the Class B Ordinary Shares represented by the ADSs at the EGM.

Additional information regarding the EGM and the Merger Agreement can be found in the transaction statement on Schedule 13E-3 and the definitive proxy statement attached as Exhibit (a)-(1) thereto, as amended, filed with the U.S. Securities and Exchange Commission (the “SEC”), which can be obtained, along with other filings containing information about the Company, the proposed Merger and related matters, without charge, from the SEC’s website (www.sec.gov), or at the SEC’s Public Reference Room at 100 F Street NE, Washington, D.C. 20549. In addition, copies of these documents can also be obtained, without charge, by contacting Eric Yuan, at +86-10-5900-1548 or by email at [email protected], or by contacting Mr. Tip Fleming, at +1 917 412 3333 or by email at [email protected].

SHAREHOLDERS AND ADS HOLDERS ARE URGED TO READ CAREFULLY AND IN THEIR ENTIRETY THESE MATERIALS AND OTHER MATERIALS FILED WITH OR FURNISHED TO THE SEC WHEN THEY BECOME AVAILABLE, AS THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE COMPANY, THE PROPOSED MERGER AND RELATED MATTERS.

The Company and certain of its directors and officers may, under SEC rules, be deemed to be “participants” in the solicitation of proxies from the Company’s shareholders with respect to the proposed Merger. Further information regarding persons who may be deemed participants, including any direct or indirect interests they may have, is set forth in the definitive proxy statement relating to the Merger.

This announcement is for information purposes only and does not constitute an offer to purchase or the solicitation of an offer to sell any securities or a solicitation of any proxy, vote or approval with respect to the proposed transaction or otherwise, nor shall it be a substitute for any proxy statement or other filings that have been or will be made with the SEC.


About Gridsum

Gridsum Holding Inc. (NASDAQ: GSUM) is a leading provider of cloud-based big-data analytics and AI solutions for multinational and domestic enterprises and government agencies in China. Gridsum’s core technology, the Gridsum Big Data Platform and the Gridsum Prophet: Enterprise AI Engine, is built on a distributed computing framework and performs real-time multi-dimensional correlation analysis of both structured and unstructured data. This enables Gridsum’s customers to identify complex relationships within their data and gain new insights that help them make better business decisions. The Company is named “Gridsum” to symbolize the combination of distributed computing (Grid) and analytics (sum). As a digital intelligence pioneer, the Company’s mission is to help enterprises and government organizations in China use data in new and powerful ways to make better-informed decisions and be more productive.

For more information, please visit http://www.gridsum.com/.


Safe Harbor Statement

This announcement contains forward-looking statements. These forward-looking statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements can be identified by terminology such as “may,” “will,” “expects,” “anticipates,” “aims,” “future,” “intends,” “plans,” “believes,” “estimates,” “likely to” and similar statements. Forward-looking statements involve inherent risks and uncertainties. Many factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the substantial doubt about the Company’s ability to continue as a going concern, duration and impact of the COVID-19 pandemically, uncertainties as to how the Company’s shareholders will vote at the extraordinary general meeting in connection with the Merger, the possibility that competing offers will be made, the possibility that financing for the Merger may not be available, the possibility that various closing conditions for the Merger may not be satisfied or waived, and other risks and uncertainties discussed in documents filed with the U.S. Securities and Exchange Commission by the Company. Further information regarding these and other risks is included in the Company’s filings with the SEC. All information provided in this press release is as of the date of this press release, and Gridsum undertakes no duty to update such information except as required under applicable law.

Investor Relations

Gridsum
[email protected]

Christensen

In China
Mr. Eric Yuan
Phone: +86-10-5900-1548
Email: [email protected]

In U.S. 
Mr. Tip Fleming 
Phone: +1 917 412 3333 
Email: [email protected]

Cision View original content:http://www.prnewswire.com/news-releases/gridsum-holding-inc-to-hold-extraordinary-general-meeting-of-shareholders-301213214.html

SOURCE Gridsum Holding Inc.

CELSION CORPORATION ANNOUNCES $35 MILLION REGISTERED DIRECT OFFERING PRICED AT-THE-MARKET UNDER NASDAQ RULES

LAWRENCEVILLE, NJ, Jan. 22, 2021 (GLOBE NEWSWIRE) — Celsion Corporation (NASDAQ: CLSN) (“Celsion” or the “Company”), today announced it has entered into definitive agreements with institutional investors for the purchase and sale of 25,925,925 shares of its common stock at a purchase price of $1.35 per share in a registered direct offering, priced at-the-market under Nasdaq rules, for gross proceeds of $35 million before deducting placement agent fees and expenses. The closing of the offering is expected to occur on or about January 26, 2021, subject to the satisfaction of customary closing conditions.

A.G.P./Alliance Global Partners is acting as lead placement agent for the offering.

Brookline Capital Markets, a division of Arcadia Securities, LLC, is acting as co-placement agent for the offering.

This offering is being made pursuant to an effective shelf registration statement on Form S-3 (File No. 333-227236) previously filed with the U.S. Securities and Exchange Commission (the “SEC”), and an additional registration statement pursuant to Rule 462(b) (File No. 333-252320) under the Securities Act of 1933, as amended. A prospectus supplement describing the terms of the proposed offering will be filed with the SEC and will be available on the SEC’s website located at http://www.sec.gov. Electronic copies of the prospectus supplement may be obtained, when available, from A.G.P./Alliance Global Partners, 590 Madison Avenue, 28th Floor, New York, NY 10022, or by telephone at (212) 624-2060, or by email at [email protected]. Before investing in this offering, interested parties should read in their entirety the prospectus supplement and the accompanying prospectus and the other documents that the Company has filed with the SEC that are incorporated by reference in such prospectus supplement and the accompanying prospectus, which provide more information about the Company and such offering.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Celsion

Celsion is a fully integrated oncology company focused on developing a portfolio of innovative cancer treatments, including immunotherapies, DNA-based therapies and directed chemotherapies. The Company’s product pipeline includes GEN-1, a DNA-based immunotherapy for the localized treatment of ovarian cancer and ThermoDox®, a proprietary heat-activated liposomal encapsulation of doxorubicin, currently in Phase III development for the treatment of primary liver cancer and in development for other cancer indications. Celsion has two feasibility stage platform technologies for the development of novel nucleic acid-based immunotherapies and other anti-cancer DNA or RNA therapies. Both are novel synthetic, non-viral vectors with demonstrated capability in nucleic acid cellular transfection. For more information on Celsion, visit: http://www.celsion.com. (CLSN-FIN).

Forward-Looking Statements

Forward-looking statements in this news release are made pursuant to the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Readers are cautioned that such forward-looking statements involve risks and uncertainties including, without limitation, statements relating to the offering and the use of proceeds therefrom, unforeseen changes in the course of research and development activities and in clinical trials; the uncertainties of and difficulties in analyzing interim clinical data, particularly in small subgroups that are not statistically significant; FDA and regulatory uncertainties and risks; the significant expense, time and risk of failure of conducting clinical trials; the need for Celsion to evaluate its future development plans; possible acquisitions or licenses of other technologies, assets or businesses; possible actions by customers, suppliers, competitors or regulatory authorities; and other risks detailed from time to time in the Celsion’s periodic filings with the Securities and Exchange Commission. Celsion assumes no obligation to update or supplement forward-looking statements that become untrue because of subsequent events, new information or otherwise.

Celsion Investor Contact

Jeffrey W. Church
Executive Vice President and CFO
609-482-2455
[email protected]
or
LHA Investor Relations
Kim Sutton Golodetz
212-838-3777
[email protected]